Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 5 studies | 35% ± 13% | |
hepatocyte | 3 studies | 39% ± 19% |
Insufficient scRNA-seq data for expression of TTPA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3146.84 | 226 / 226 | 95% | 57.62 | 387 / 406 |
brain | 98% | 155.14 | 2595 / 2642 | 82% | 5.02 | 578 / 705 |
intestine | 74% | 69.98 | 717 / 966 | 73% | 5.72 | 385 / 527 |
breast | 86% | 60.58 | 396 / 459 | 33% | 1.13 | 369 / 1118 |
stomach | 41% | 14.98 | 148 / 359 | 56% | 5.56 | 161 / 286 |
adipose | 94% | 93.32 | 1129 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 80% | 35.23 | 262 / 328 | 11% | 0.17 | 19 / 178 |
lung | 68% | 31.47 | 395 / 578 | 14% | 0.57 | 165 / 1155 |
kidney | 71% | 39.88 | 63 / 89 | 3% | 0.08 | 31 / 901 |
bladder | 24% | 5.86 | 5 / 21 | 32% | 2.38 | 163 / 504 |
skin | 12% | 4.57 | 223 / 1809 | 38% | 1.21 | 178 / 472 |
adrenal gland | 37% | 9.66 | 95 / 258 | 9% | 0.22 | 21 / 230 |
esophagus | 16% | 3.97 | 225 / 1445 | 24% | 0.84 | 44 / 183 |
ovary | 2% | 0.39 | 3 / 180 | 30% | 0.70 | 128 / 430 |
eye | 0% | 0 | 0 / 0 | 30% | 0.87 | 24 / 80 |
blood vessel | 27% | 8.32 | 364 / 1335 | 0% | 0 | 0 / 0 |
uterus | 8% | 1.99 | 14 / 170 | 16% | 0.51 | 75 / 459 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.26 | 6 / 45 |
prostate | 10% | 2.52 | 24 / 245 | 1% | 0.01 | 4 / 502 |
heart | 6% | 1.57 | 51 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 0.82 | 14 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.32 | 11 / 803 | 0% | 0 | 0 / 0 |
spleen | 1% | 5.68 | 2 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.17 | 2 / 653 | 0% | 0 | 0 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0051180 | Biological process | vitamin transport |
GO_0009636 | Biological process | response to toxic substance |
GO_0090212 | Biological process | negative regulation of establishment of blood-brain barrier |
GO_0006629 | Biological process | lipid metabolic process |
GO_1900223 | Biological process | positive regulation of amyloid-beta clearance |
GO_0042360 | Biological process | vitamin E metabolic process |
GO_0001892 | Biological process | embryonic placenta development |
GO_0005829 | Cellular component | cytosol |
GO_0005770 | Cellular component | late endosome |
GO_1902936 | Molecular function | phosphatidylinositol bisphosphate binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0005515 | Molecular function | protein binding |
GO_0120013 | Molecular function | lipid transfer activity |
GO_0008431 | Molecular function | vitamin E binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
Gene name | TTPA |
Protein name | Alpha-tocopherol transfer protein (Alpha-TTP) |
Synonyms | TPP1 |
Description | FUNCTION: Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells . Binds both phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate; the resulting conformation change is important for the release of the bound alpha-tocopherol (By similarity). . |
Accessions | P49638 ENST00000260116.5 |